Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Glucocorticoid, used to initiate therapy |
|
|
Term
|
Definition
| Decreases Tcell activation |
|
|
Term
|
Definition
| inhibits IL1 and TNF-α release |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| BRM, TNF-α Receptor-like protein |
|
|
Term
|
Definition
| BRM, Chimeric (mouse), antibody to TNF-α |
|
|
Term
|
Definition
| BRM, Fully-human antibody to TNF-α |
|
|
Term
|
Definition
| BRM, IL1 Receptor antagonist |
|
|
Term
|
Definition
| BRM, Reduces Tcell activation/Incrases Tcell apoptosis |
|
|
Term
|
Definition
| BRM, IL6 receptor antagonist |
|
|
Term
|
Definition
| BRM, anti-CD20, reduces Bcells |
|
|
Term
|
Definition
| Gout, prevents tubulin polymerization --> reduces pain and inflammation fast |
|
|
Term
|
Definition
Gout, uricosuric agent, organic acid competes with urate for reabsorption
Sfx: GI irritation, low urate can induce acute gout, reduced secretion of penicillin |
|
|
Term
|
Definition
Gout, Xanthine oxidase competitive inhibitor (alloxanthine non-competitive inhibitor)
Sfx: acute attacks of gout possible initially, urate mobilized from tissues |
|
|
